Nefrofer

• Iron deficiency anaemia (where oral therapy is ineffective or impracticable)

Adult Dose (Parenteral):

• Iron-deficiency anaemia: 25-100 mg IV or deep IM daily PRN; not to exceed 100 mg (2 mL)/day
• Total dose (mL): 0.0442 (desired Hgb - observed Hgb) x LBW + (0.26 x LBW)
• Blood loss: total iron dose in mg = blood loss (mL) x HCT
• A test dose of 0.5 mL should be given and observe patient for at least 1 hour

Child Dose (5-15 kg):

• Not to be given in first 4 months of life
• Dose = 0.0442(Desired Hgb - Observed Hgb) x BW(kg) + (0.26 × BW)

1-10%:

• Abdominal pain, Diarrhea, Nausea, Vomiting
• Arthralgia, Arthritis
• Soreness, Inflammation, Pruritus, Rash, Urticaria
• Brown discoloration of skin

Frequency Not Defined: Seizure, Chest pain, Hypotensive shock, Dyspnea, Respiratory arrest, Leukocytosis, Anaphylaxis, Hematuria

Use in Pregnancy: Category C; animal studies have shown adverse effect on fetus; no adequate human studies; potential benefits may warrant use despite potential risks.

Precautions:

• Parenterally administered iron preparations can cause serious and potentially fatal anaphylactic/anaphylactoid reactions
• Hypersensitivity reactions have been reported after previously uneventful doses
• Risk is enhanced for patients with known allergies, severe asthma, eczema or other atopic allergy
• Hypotensive episodes may occur if intravenous injection is administered too rapidly
• Lactation: traces excreted in breast milk, use caution

Overdose: May cause iron overload; haemochromatosis or haemosiderosis may occur; symptomatic treatment; deferoxamine chelation therapy may be considered.